Search results
New Alzheimer’s drug wins approval after FDA delay
Deseret News· 3 hours agoPatients and their families will have to weigh that benefit against the downsides, including regular IV infusions and potentially dangerous side effects...
These two stocks can act as Rahul Dravid of your portfolio: Gautam Shah
The Economic Times· 21 hours agoGautam Shah: Well, pharma has been a brilliant story for the last one year. Now it saw a breakout...
Look for stocks with less downward volatility and stable earnings prospects: Anand Tandon
The Economic Times· 1 day agoHow do you see the power sector from the market standpoint? Despite all the activity, the market...
F&O Talk: Go long in Nifty, Bank Nifty with buying on declines, says Shilpa Rout of Prabhudas...
The Economic Times· 3 days agoFrontline indices Nifty50 and Bank Nifty scaled new highs of 24,174 and 53,180 points, respectively,...
Only 17% of targets to improve life around the world are likely to be reached by 2030, UN reports
The Economic Times· 4 days agoThe United Nations warned Friday that only 17% of its 169 targets to improve life for the world's...
Buy on dips as Nifty & Bank Nifty look bullish; 3 stocks to bet on: Rajesh Palviya
The Economic Times· 4 days agoRajesh Palviya, Head-Technical Research, Axis Securities, says put writers are aggressive at 24,000...
Expect a rally in PSU bank stocks in next few days: Vinit Bolinjkar
The Economic Times· 4 days agoThroughout this week, banks were the clear standout gainers, especially the private sector banks....
What Are the Disadvantages of Mobile Phones?
LOVE to KNOW· 5 days agoPrivacy and Tracking Concerns One of the handiest elements of a smartphone is its ability to provide information about stores and services in your...
NFL Hit With $4.7 Billion Damages in Sunday Ticket Trial
Livemint· 5 days agoThe National Football League was hit with about $4.7 billion in damages — which stands to be tripled to $14 billion under federal law — after losing a jury trial over anticompetitive features ...
Exide has surged 80% but still not overvalued? Sudip Bandyopadhyay explains why
The Economic Times· 7 days agoSudip Bandyopadhyay, Group Chairman, Inditrade Capital, says fertilizers and agrochemicals is one...